Related content

A 2-year follow-up study of patients participating in our transcranial pulsating electromagnetic fields augmentation in treatment-resistant depression

By  

Acta Neuropsychiatrica, Vol. 27, Iss. 2, 2015-01 ,pp. : 119-125

Cambridge University Press

Access to resources Recommend Favorite

The Diagnostic Apathia Scale predicts a dose–remission relationship of T-PEMF in treatment-resistant depression

By  

Acta Neuropsychiatrica, Vol. 27, Iss. 1, 2014-10 ,pp. : 1-7

Cambridge University Press

Access to resources Recommend Favorite

A Pilot Double Blind Randomized Placebo Controlled Trial of a Prototype Computer-Based Cognitive Behavioural Therapy Program for Adolescents with Symptoms of Depression

By  

Behavioural and Cognitive Psychotherapy, Vol. 42, Iss. 4, 2014-07 ,pp. : 385-401

Cambridge University Press

Access to resources Recommend Favorite

Psychometric analysis of the Melancholia Scale in trials with non-pharmacological augmentation of patients with therapy-resistant depression

By  

Acta Neuropsychiatrica, Vol. 26, Iss. 3, 2013-10 ,pp. : 155-160

Cambridge University Press

Access to resources Recommend Favorite

Asenapine for the treatment of adults with an acute exacerbation of schizophrenia: results from a randomized, double-blind, fixed-dose, placebo-controlled trial with olanzapine as an active control

By  

CNS Spectrums, Vol. 22, Iss. 4, 2016-11 ,pp. : 333-341

Cambridge University Press

Access to resources Recommend Favorite